Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Melanoma treatment details. Chemotherapy. Addenbrooke’s Hospital, Cambridge, United Kingdom



Survival: 5.9 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: United Kingdom
   
City/State/Province: Cambridge
   
Hospital: Addenbrooke’s Hospital
   
Journal: Link
   
Date: 1/2010

Description:
Patients:
This study involved 152 patients with metastatic malignant melanoma. The median patient age was 62 years and 54.6% were male.

Treatment:
Patients were treated with the chemotherapy agent lenalidomide.

Toxicities:
There was one treatment-related death due to dyspnea (shortness of breath). Grade 3-4 constipation, nausea, fatigue, diarrhea, and neutropenia were also reported.

Results:
The median overall survival was 5.9 months.

Support:
This study was supported by Celgene, makers of Revlimid (lenalidomide).

Correspondence: Dr. Tim Eisen; email: tgqe2@cam.ac.uk

E-mail to a Friend Email Physician More Information